Global Digital Biomarker Market 2026 by Company, Regions, Type and Application, Forecast to 2032
Description
According to our (Global Info Research) latest study, the global Digital Biomarker market size was valued at US$ 3724 million in 2025 and is forecast to a readjusted size of US$ 225140 million by 2032 with a CAGR of 80.6% during review period.
Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected are typically used to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data.
Digital biomarkers refer to biomedical data collected and analyzed through digital technology, which are used to detect, monitor and predict disease biomarkers. These data are usually collected through technologies such as smart devices, wearable sensors, and mobile applications, including physiological data such as heart rate, gait, blood sugar, brain waves, and sleep patterns. In recent years, with the rapid development of technologies such as artificial intelligence, big data analysis, and the Internet of Things (IoT), digital biomarkers have gradually shown great potential in disease diagnosis, efficacy evaluation, and health management.
At present, the digital biomarker market is in a rapid development stage. The popularity of digital health devices and the demand for personalized medicine and precision medicine have promoted the research and application of digital biomarkers. In the early diagnosis and monitoring of some chronic disease management and neurodegenerative diseases (such as Alzheimer's disease and Parkinson's disease), digital biomarkers have shown significant application value. In addition, digital biomarkers are also playing an increasingly important role in the drug development process, especially in the recruitment of patients in clinical trials, monitoring of treatment effects, and evaluation of side effects.
In the future, digital biomarkers are expected to be more widely used in multiple fields. First, with the continuous advancement of artificial intelligence and machine learning algorithms, the analytical capabilities of digital biomarkers will become more accurate and efficient, which will help to formulate more personalized treatment plans. Secondly, with the popularization of 5G technology, the improvement of real-time data transmission capabilities will enable digital biomarkers to monitor patients' health status in real time and increase the possibility of early detection of diseases. In addition, cross-industry cooperation and standardization of digital biomarkers will also promote their widespread application around the world.
Philips and Novartis are the top 2 companies in global digital biomarker market and account for over 15% of total market share. Geographically speaking, Europe holds about 45% of global market share, followed by North America with about 35% share. In terms of type, passive digital biomarker segment holds an important share of about 65%. In terms of application, clinical disease segment accounts for about 80% of the total share.
This report is a detailed and comprehensive analysis for global Digital Biomarker market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Digital Biomarker market size and forecasts, in consumption value ($ Million), 2021-2032
Global Digital Biomarker market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Digital Biomarker market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Digital Biomarker market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Digital Biomarker
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Digital Biomarker market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Philips, Johnson & Johnson, Pfizer, GE Healthcare, Novartis, Apple, Sanofi, GlaxoSmithKline, Bayer, Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Digital Biomarker market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Passive Digital Biomarker
Active Digital Biomarker
Market segment by Application
Clinical Disease
Daily Health
Market segment by players, this report covers
Philips
Johnson & Johnson
Pfizer
GE Healthcare
Novartis
Apple
Sanofi
GlaxoSmithKline
Bayer
Merck
Abbott Laboratories
Asahi Kasei
Biogen
Koneksa Health
Roche
Huma Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Digital Biomarker product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Digital Biomarker, with revenue, gross margin, and global market share of Digital Biomarker from 2021 to 2026.
Chapter 3, the Digital Biomarker competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Digital Biomarker market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Digital Biomarker.
Chapter 13, to describe Digital Biomarker research findings and conclusion.
Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected are typically used to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data.
Digital biomarkers refer to biomedical data collected and analyzed through digital technology, which are used to detect, monitor and predict disease biomarkers. These data are usually collected through technologies such as smart devices, wearable sensors, and mobile applications, including physiological data such as heart rate, gait, blood sugar, brain waves, and sleep patterns. In recent years, with the rapid development of technologies such as artificial intelligence, big data analysis, and the Internet of Things (IoT), digital biomarkers have gradually shown great potential in disease diagnosis, efficacy evaluation, and health management.
At present, the digital biomarker market is in a rapid development stage. The popularity of digital health devices and the demand for personalized medicine and precision medicine have promoted the research and application of digital biomarkers. In the early diagnosis and monitoring of some chronic disease management and neurodegenerative diseases (such as Alzheimer's disease and Parkinson's disease), digital biomarkers have shown significant application value. In addition, digital biomarkers are also playing an increasingly important role in the drug development process, especially in the recruitment of patients in clinical trials, monitoring of treatment effects, and evaluation of side effects.
In the future, digital biomarkers are expected to be more widely used in multiple fields. First, with the continuous advancement of artificial intelligence and machine learning algorithms, the analytical capabilities of digital biomarkers will become more accurate and efficient, which will help to formulate more personalized treatment plans. Secondly, with the popularization of 5G technology, the improvement of real-time data transmission capabilities will enable digital biomarkers to monitor patients' health status in real time and increase the possibility of early detection of diseases. In addition, cross-industry cooperation and standardization of digital biomarkers will also promote their widespread application around the world.
Philips and Novartis are the top 2 companies in global digital biomarker market and account for over 15% of total market share. Geographically speaking, Europe holds about 45% of global market share, followed by North America with about 35% share. In terms of type, passive digital biomarker segment holds an important share of about 65%. In terms of application, clinical disease segment accounts for about 80% of the total share.
This report is a detailed and comprehensive analysis for global Digital Biomarker market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Digital Biomarker market size and forecasts, in consumption value ($ Million), 2021-2032
Global Digital Biomarker market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Digital Biomarker market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Digital Biomarker market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Digital Biomarker
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Digital Biomarker market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Philips, Johnson & Johnson, Pfizer, GE Healthcare, Novartis, Apple, Sanofi, GlaxoSmithKline, Bayer, Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Digital Biomarker market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Passive Digital Biomarker
Active Digital Biomarker
Market segment by Application
Clinical Disease
Daily Health
Market segment by players, this report covers
Philips
Johnson & Johnson
Pfizer
GE Healthcare
Novartis
Apple
Sanofi
GlaxoSmithKline
Bayer
Merck
Abbott Laboratories
Asahi Kasei
Biogen
Koneksa Health
Roche
Huma Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Digital Biomarker product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Digital Biomarker, with revenue, gross margin, and global market share of Digital Biomarker from 2021 to 2026.
Chapter 3, the Digital Biomarker competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Digital Biomarker market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Digital Biomarker.
Chapter 13, to describe Digital Biomarker research findings and conclusion.
Table of Contents
121 Pages
- 1 Market Overview
- 2 Company Profiles
- 3 Market Competition, by Players
- 4 Market Size Segment by Type
- 5 Market Size Segment by Application
- 6 North America
- 7 Europe
- 8 Asia-Pacific
- 9 South America
- 10 Middle East & Africa
- 11 Market Dynamics
- 12 Industry Chain Analysis
- 13 Research Findings and Conclusion
- 14 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
